From GlobeNewswire:

The global gastroesophageal reflux disease (GERD) market is set to grow at a CAGR of 2.0% to reach $5.25 billion by 2024, driven by lifestyle changes and increased awareness. By 2028, the market is projected to hit $5.74 billion, fueled by factors like an aging population and advancements in healthcare services and procedures.

Alcohol consumption plays a significant role in the market’s growth, with rising per capita ethanol consumption contributing to the prevalence of GERD. Major players like GlaxoSmithKline and Pfizer are investing in innovative treatments, such as wireless pH-capsule reflux testing systems, to meet the growing demand for GERD solutions.

Market segmentation includes drug types like antacids and proton pump inhibitors, procedures such as invasive and minimally invasive, and end-users like hospitals and specialty clinics. While North America leads currently, Asia-Pacific is expected to show the fastest growth in the forecast period, highlighting the global nature of the GERD market.

To succeed in this dynamic market, companies must embrace innovation and agility. The Business Research Company provides detailed insights and analysis on the GERD market size, trends, competitors, and more, enabling informed decision-making for stakeholders. Their comprehensive reports cover over 2,500 market segments and 60 geographies, offering valuable industry intelligence for strategic planning.



Read more at GlobeNewswire: Rapid Growth Anticipated in the Gastroesophageal Reflux